Literature DB >> 12657195

Recombinant tissue plasminogen activator in the treatment of intraventricular hemorrhage secondary to periventricular arteriovenous malformation before surgery: case report.

Krishna Kumar1, Denny D Demeria, Ashok Verma.   

Abstract

OBJECTIVE AND IMPORTANCE: Intraventricular hemorrhage (IVH) is known to cause acute obstructive hydrocephalus, refractory elevated intracranial pressures (ICPs), and lowered cerebral perfusion pressures, leading to cortical ischemia. Frequent obstruction of external ventricular drains as a result of thrombus is a recurring theme. We present a case of IVH secondary to periventricular arteriovenous malformation (AVM) that was not visible at admission angiography and was treated by intraventricular infusion of recombinant tissue plasminogen activator before surgical intervention. CLINICAL
PRESENTATION: An 11-year-old boy presented with acute onset of headache followed by two seizures, loss of consciousness, decerebration, right temporal hematoma, IVH, and acute obstructive hydrocephalus. INTERVENTION: A right external ventricular drain was placed but functioned poorly. ICP could not be controlled by conventional methods. Five milligrams of recombinant tissue plasminogen activator was injected into the ventricular system via the external ventricular drain. This was repeated daily for 4 days. This treatment resulted in progressive improvement in ICP and clinical status. Once the clot partially cleared, magnetic resonance imaging and magnetic resonance angiography suggested the presence of a right periventricular arteriovenous malformation, which was confirmed by angiography and subsequently resected.
CONCLUSION: Recombinant tissue plasminogen activator is effective in resolving IVH causing obstructive hydrocephalus and uncontrollable ICP posing a life-threatening situation, secondary to ruptured arteriovenous malformation, before surgical intervention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657195     DOI: 10.1227/01.neu.0000053028.06474.c6

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

Review 1.  External ventricular drainage for intraventricular hemorrhage.

Authors:  Mahua Dey; Jennifer Jaffe; Agnieszka Stadnik; Issam A Awad
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 2.  Spontaneous intracerebral and intraventricular hemorrhage: advances in minimally invasive surgery and thrombolytic evacuation, and lessons learned in recent trials.

Authors:  Mahua Dey; Agnieszka Stadnik; Issam A Awad
Journal:  Neurosurgery       Date:  2014-02       Impact factor: 4.654

3.  Intraventricular hemorrhage secondary to intranidal aneurysm rupture-successful management by arteriovenous malformation embolization followed by intraventricular tissue plasminogen activator: case report.

Authors:  Glen A Pollock; Ali Shaibani; Issam Awad; H Hunt Batjer; Bernard R Bendok
Journal:  Neurosurgery       Date:  2011-02       Impact factor: 4.654

4.  Intraventricular thrombolysis after endovascular treatment of a ruptured arteriovenous malformation.

Authors:  Arthur Wang; Abhishek Ray; Yin C Hu
Journal:  BMJ Case Rep       Date:  2016-05-24

5.  Safety of Intraventricular rt-PA for Pan-Ventricular IVH Caused by a Ruptured AVM: A Case Report.

Authors:  Sushrut Dharmadhikari; Ashutosh Mahapatra; Anita Tipirneni; Dileep Yavagal; Amer M Malik
Journal:  Neurohospitalist       Date:  2017-01-31

Review 6.  Thrombolytic evacuation of intracerebral and intraventricular hemorrhage.

Authors:  Mahua Dey; Agnieszka Stadnik; Issam A Awad
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

Review 7.  Minimally Invasive Surgery for Intracerebral and Intraventricular Hemorrhage.

Authors:  Zelong Zheng; Qi Wang; Shujie Sun; Jinbiao Luo
Journal:  Front Neurol       Date:  2022-02-22       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.